|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine - Cardiology, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA
* To whom correspondence should be addressed. E-mail: hallx068{at}umn.edu.
Initial studies established expression of the novel low density lipoprotein (LDL) receptor related protein 6 (LRP6) in vascular smooth muscle cells (VSMC). We hypothesized that LRP6 was a critical mediator governing the regulation of the canonical Wnt/
-catenin/(Tcf-4) cascade in the vasculature. This hypothesis was based on our previous work demonstrating a role for the
-catenin/Tcf-4 pathway in vascular remodeling as well as work in other cell systems establishing a role for LRP family members in the Wnt cascade. In line with our hypothesis, LRP6 up-regulation significantly increased Wnt-1-induced Tcf activation. Moreover, a dominant interfering LRP6 mutant lacking the carboxyl intracellular domain (LRP6deltaC) abolished Tcf activity. LRP6 induced stimulation of Tcf was blocked in VSMC harboring constitutive expression of a dominant negative Tcf-4 transgene lacking the
-catenin binding domain (Tcf-4(N31). This suggested that LRP6-induced activation of Tcf was mediated through a
-catenin-dependent signal. Expression of the dominant interfering LRP6deltaC transgene was sufficient to abolish the Wnt-induced survival as well as cyclin D1 activity and cell cycle progression. In conclusion, these findings provide the first evidence of a role for an LDL receptor related protein in the regulation of VSMC growth and fate through the evolutionary conserved Wnt signaling cascade.
This article has been cited by other articles:
![]() |
A. Giordano, S. Romano, M. Mallardo, A. D'Angelillo, G. Cali, N. Corcione, P. Ferraro, and M. F. Romano FK506 can activate transforming growth factor-{beta} signalling in vascular smooth muscle cells and promote proliferation Cardiovasc Res, August 1, 2008; 79(3): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. George Wnt Pathway: A New Role in Regulation of Inflammation Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 400 - 402. [Full Text] [PDF] |
||||
![]() |
T. Couffinhal, P. Dufourcq, and C. Duplaa {beta}-Catenin Nuclear Activation: Common Pathway Between Wnt and Growth Factor Signaling in Vascular Smooth Muscle Cell Proliferation? Circ. Res., December 8, 2006; 99(12): 1287 - 1289. [Full Text] [PDF] |
||||
![]() |
X. Wang, Q. Hu, A. Mansoor, J. Lee, Z. Wang, T. Lee, A. H. L. From, and J. Zhang Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1393 - H1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Haines, N. Schnetz-Boutaud, S. Schmidt, W. K. Scott, A. Agarwal, E. A. Postel, L. Olson, S. J. Kenealy, M. Hauser, J. R. Gilbert, et al. Functional Candidate Genes in Age-Related Macular Degeneration: Significant Association with VEGF, VLDLR, and LRP6 Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 329 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahmani, J. T. Read, J. M. Carthy, P. C. McDonald, B. W. Wong, M. Esfandiarei, X. Si, Z. Luo, H. Luo, P. S. Rennie, et al. Regulation of the Versican Promoter by the {beta}-Catenin-T-cell Factor Complex in Vascular Smooth Muscle Cells J. Biol. Chem., April 1, 2005; 280(13): 13019 - 13028. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |